LD-2 disclosure · 4th Quarter - Amendment
HELIX, INC.
via HELIX, INC.
Client
- Name
- HELIX, INC.
- Location
- California · United States of America
Registrant
- Firm
- HELIX, INC.
- Description
- Genomics
- Location
- San Mateo, California, United States of America
Lobbying activities
3 issuesHealth Issues
Human and Viral Genomic research, testing,funding and insurance coverage, pandemic preparedness, viral surveillance, Lab Developed Tests H791 and S236 COVID-19 Variants Data Tracking (viral sequencing and analytic supports) H6584 Clinical Trial Diversity H 7667 Rx Drug and Device User Fee Programs (regulation of Lab Developed Tests) H 4128 VALID Act (regulation of Lab Developed Tests) H 2471 Omnibus (PREVENT Pandemics Act, funding for Advanced Molecular Detection, and VALID Act) S2022 Whole Genome Sequencing Clinic (Whole Exome sequencing)
Lobbyistsmrs KELLI ARTHUR HYKES
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Office of Management & Budget (OMB) · Centers For Disease Control & Prevention (CDC)
Medical/Disease Research/Clinical Labs
viral and human genomic research, testing,funding and insurance coverage, COVID-19 testing and research, Lab Developed Tests H791 and S236 COVID-19 Variants Data Tracking (viral sequencing and analytic supports) H6584 Clinical Trial Diversity H 7667 Rx Drug and Device User Fee Programs (regulation of Lab Developed Tests) H 4128 VALID Act (regulation of Lab Developed Tests) H 2471 Omnibus (PREVENT Pandemics Act, funding for Advanced Molecular Detection, and VALID Act) S2022 Whole Genome Sequencing Clinic (Whole Exome sequencing)
Lobbyistsmrs KELLI ARTHUR HYKES
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Office of Management & Budget (OMB) · Centers For Disease Control & Prevention (CDC)